The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-bromo-2-(((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methyl)thio)-8-nitro-4H-benzo[e][1,3]thiazin-4-one ID: ALA5197370
PubChem CID: 168286398
Max Phase: Preclinical
Molecular Formula: C17H9BrClN5O3S2
Molecular Weight: 510.78
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=c1nc(SCc2cn(-c3ccc(Cl)cc3)nn2)sc2c([N+](=O)[O-])cc(Br)cc12
Standard InChI: InChI=1S/C17H9BrClN5O3S2/c18-9-5-13-15(14(6-9)24(26)27)29-17(20-16(13)25)28-8-11-7-23(22-21-11)12-3-1-10(19)2-4-12/h1-7H,8H2
Standard InChI Key: NBJYKUXFWSNRFB-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
1.8698 -0.8963 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6903 -0.8101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1751 -1.4775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9957 -1.3913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3313 -0.6375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1518 -0.5513 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.8463 0.0298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0258 -0.0564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3177 -0.2832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5639 -0.6187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1504 -0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8649 -0.6187 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.5793 -0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5793 0.6187 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.2939 1.0311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2939 1.8562 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.0084 0.6187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0084 -0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7228 -0.6187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4372 -0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4372 0.6187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7228 1.0311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1518 1.0311 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
-3.7228 -1.4438 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.4372 -1.8562 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.0084 -1.8562 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.2939 -0.6187 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.6502 -1.4392 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4572 -1.6107 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
5 7 2 0
7 8 1 0
8 2 2 0
9 1 1 0
9 10 2 0
11 10 1 0
12 11 1 0
13 12 1 0
13 14 2 0
14 15 1 0
15 16 2 0
17 15 1 0
18 17 2 0
19 18 1 0
20 19 2 0
21 20 1 0
17 22 1 0
22 21 2 0
21 23 1 0
19 24 1 0
24 25 1 0
24 26 2 0
18 27 1 0
27 13 1 0
28 10 1 0
29 28 2 0
1 29 1 0
M CHG 2 24 1 25 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 510.78Molecular Weight (Monoisotopic): 508.9019AlogP: 4.85#Rotatable Bonds: 5Polar Surface Area: 103.81Molecular Species: NEUTRALHBA: 9HBD: ┄#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 5.37CX LogD: 5.37Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.21Np Likeness Score: -2.27
References 1. Sahoo SK, Ahmad MN, Kaul G, Nanduri S, Dasgupta A, Chopra S, Yaddanapudi VM.. (2022) Synthesis and evaluation of triazole congeners of nitro-benzothiazinones potentially active against drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy., 13 (5.0): [PMID:35694687 ] [10.1039/d1md00387a ]